viewClearStar Inc

ClearStar passes US$1mln monthly sales landmark

Growth in Medical Information Services has been driven by demand for its mobile solution, ClearID, and an enhancement to services

ClearStar Inc -
The company is able to help employers screen for alcohol and drugs

Screening specialist ClearStar Inc (LON:CLSU) said its Medical Information Services (MIS) business has passed a significant milestone by posting monthly sales in excess of US$1mln for the first time.

Growth has been driven by demand for its mobile solution, ClearID, and an enhancement to services to bring in breath tests for alcohol and drugs.

MIS revenues were US$1.06mln in July, up 37% on the same period a year ago and are ahead 27% for the year to July 31. They accounted for 47% of total turnover.

"We are proud to have achieved this milestone of over $1 million in monthly revenue for Medical Information Services,” said chief executive Robert Vale.

 “We are receiving ever-growing demand as customers increasingly recognise the value that our solutions can add to their screening programmes - to benefit both the employer and the employee.

“We are also pleased to introduce our new combined drug and breath alcohol testing service, which is the first step towards our goal of providing complete medical review services."

Quick facts: ClearStar Inc

Price: 39.5 GBX

Market: AIM
Market Cap: £14.36 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of ClearStar Inc named herein, including the promotion by the Company of ClearStar Inc in any Content on the Site, the Company receives from said...


ClearStar reveals increased revenue numbers driven by new types of...

ClearStar Inc (LON:CLSU) CEO Robert Vale tells Proactive the company has reported positive financial metrics for 2019, moving into new lines of business including the petrochemical space. Vale says increased medical service demand, new types of screening services drove growth for the...

on 05/07/2020

2 min read